BSL — Raffles Medical Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapHigh Flyer

Annual cashflow statement for Raffles Medical, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	64.7	83.7	144	91.1	62.3
Depreciation
Amortisation
Non-Cash Items	35	44.6	74.3	20.5	28
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-2	-7.57	-62	39.4	-47.1
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	133	160	196	189	86.3
Capital Expenditures	-60.1	-52.8	-25.3	-21.9	-20.9
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-2.13	0.605	2.47	9.53	11
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-62.2	-52.2	-22.8	-12.4	-9.87
Financing Cash Flow Items	-6.03	-7.3	-6.8	-5.12	-6.6
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-20.9	-46.9	-184	-85.5	-76.2
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	51.3	61.9	-11.9	90.5	1.13